| 0 |
VASCULAR ACCESS SITE THROMBOSIS |
1 |
0.0200 |
| 1 |
FRACTIONAL EXHALED NITRIC OXIDE INCREASED |
3 |
0.0168 |
| 2 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
3 |
0.0021 |
| 3 |
MYOGLOBIN BLOOD INCREASED |
3 |
0.0020 |
| 4 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
3 |
0.0010 |
| 5 |
PLANTAR FASCIITIS |
3 |
0.0009 |
| 6 |
FOREIGN BODY IN THROAT |
2 |
0.0006 |
| 7 |
INCREASED UPPER AIRWAY SECRETION |
2 |
0.0004 |
| 8 |
SENSATION OF FOREIGN BODY |
3 |
0.0004 |
| 9 |
EXOSTOSIS |
3 |
0.0003 |
| 10 |
OBSTRUCTIVE AIRWAYS DISORDER |
3 |
0.0003 |
| 11 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 12 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 13 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 14 |
PNEUMOTHORAX |
3 |
0.0002 |
| 15 |
EOSINOPHILIA |
3 |
0.0002 |
| 16 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 17 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 18 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 19 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 20 |
BRONCHOSPASM |
2 |
0.0001 |
| 21 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 22 |
CORONARY ARTERY DISEASE |
3 |
0.0001 |
| 23 |
JOINT INJURY |
2 |
0.0001 |
| 24 |
WRIST FRACTURE |
1 |
0.0001 |
| 25 |
LIVER INJURY |
2 |
0.0001 |
| 26 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 27 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 28 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
3 |
0.0001 |
| 29 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 30 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 31 |
DYSPHONIA |
3 |
0.0001 |
| 32 |
WHEEZING |
3 |
0.0001 |
| 33 |
HEPATOTOXICITY |
1 |
0.0000 |
| 34 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 35 |
PRESYNCOPE |
1 |
0.0000 |
| 36 |
JOINT STIFFNESS |
1 |
0.0000 |
| 37 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 38 |
CARDIAC DISORDER |
3 |
0.0000 |
| 39 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 40 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 41 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 42 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 43 |
MENTAL DISORDER |
1 |
0.0000 |
| 44 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 45 |
INFLAMMATION |
1 |
0.0000 |
| 46 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 47 |
BRADYCARDIA |
1 |
0.0000 |
| 48 |
ARTHROPATHY |
1 |
0.0000 |
| 49 |
MUSCLE SPASMS |
3 |
0.0000 |
| 50 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 51 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 52 |
SLEEP DISORDER |
1 |
0.0000 |
| 53 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 54 |
TREATMENT FAILURE |
1 |
0.0000 |
| 55 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 56 |
COUGH |
3 |
0.0000 |
| 57 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 58 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 59 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 60 |
JOINT SWELLING |
1 |
0.0000 |
| 61 |
DYSPNOEA |
4 |
0.0000 |
| 62 |
INFECTION |
1 |
0.0000 |
| 63 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 64 |
DRUG INTERACTION |
1 |
0.0000 |
| 65 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 66 |
WEIGHT INCREASED |
1 |
0.0000 |
| 67 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 68 |
INSOMNIA |
1 |
0.0000 |
| 69 |
ANXIETY |
1 |
0.0000 |
| 70 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 71 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 72 |
PNEUMONIA |
1 |
0.0000 |
| 73 |
ARTHRALGIA |
1 |
0.0000 |
| 74 |
OFF LABEL USE |
1 |
0.0000 |
| 75 |
DRUG INEFFECTIVE |
1 |
0.0000 |